RE: Message for Myles McNulty23 Dec 2021 17:09
Thanks @iceman888:
Here is his tweet:
----------------------
@UKHSA @DHSCgovuk:
British Co @avacta, owner of one of the world’s best SARS-CoV-2 LFTs, has been granted not only Pro-Use by the EU, but now Self-Use. The latter is INFINITELY more difficult to secure. Yet you still forbid #AVCT to sell in the UK even as just Pro-Use. Why?
Again, I suggest this gets flagged to the UK media. @avacta #AVCT’s best-in-class LFT can be sold not only to hospitals, airlines, and businesses throughout Mainland Europe; but now, with CE Mark for self-use, can be sold in retail stores and online directly to the public. How can this be possible?
British innovation (Yorkshire!) has created a world-beating product; the EU has given it the highest possible authorisation - home-use status (a product that anyone can buy in a shop. Yet the UK Gov itself won’t even permit a healthcare pro to use the #AVCT LFT on a patient. Something is fundamentally wrong at the @UKHSA. Many have suggested blame lies with
@JimBethell. Although in my view he’s not without fault, I’d suggest the root cause is the people who set the test parameters for diagnostic tests early on in the pandemic - and now are too scared to change said parameters of passing tests, for fear of looking like imbeciles for having set them in the first place.
I’d also suggest that there’s some enmity present now. A couple of members of the Oversight Committee? Just to make clear to journalists:
@avacta, a UK-based Co, has created an industry-leading product (a COVID-19 lateral flow test). The EU evidently rates the LFT, and has given #AVCT authorisation to sell all over Europe. The UK Gov has blocked ALL sales in the UK.
Sign In
Follow the stocks
